New hair loss gel enters human safety testing
Disease control
Completed
This early-stage trial tested the safety of a new topical gel called AH-001 in 64 healthy volunteers and men with male pattern baldness. Participants received either a single dose or daily doses for a week of the gel or a placebo. The study focused on side effects and how the dru…
Phase: PHASE1 • Sponsor: AnHorn Medicines Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC